Hole-in-one: simple non-surgical technique for the management of anterior chamber migrated Ozurdex implant by Rivera Pérez de Rada, Pablo et al.
Hole-in-one: simple non-surgical technique for the
management of anterior chamber migrated Ozurdex®
implant
Abstract
Introduction: Themigration of a dexamethasone implant to the anterior
chamber is a vision-threatening complication which can happen in non-
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compartmentalized eyes treated with this device. Previous literature
Pedro
Fernández-Avellaneda1
suggests that the solution to this complication is almost always surgical
and in most cases cannot be delayed.
Case description: We present the case of a 78-year-old woman with a
scleral-fixated IOL andmacular edema treated with Ozurdex®. She came
Lucía Teresa Barturen
Herraiz1
to us complaining of blurred vision and was subsequently diagnosed
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with an anterior-chamber migration of her dexamethasone implant.
Postural manoeuvres were performed until the dexamethasone implant
returned to the vitreous cavity through the pupil. Pilocarpine drops were Estibaliz Ispizua
Mendivil1prescribed with a positive outcome and no further migrations were de-
scribed.
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Discussion: This case shows a practical and efficient way of managing
a potentially vision-threatening complication without placing the patient
onto an operating table. It is interesting to see how it is possible to re- Javier
Hidalgo-Santamaría2locate a dexamethasone implant despite the presence of a scleral-
fixated IOL.
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Conclusion: Postural manoeuvres are an interesting option in patients
with a dexamethasone implant migrated to the anterior chamber. This
approach can have very positive outcomes, in addition to avoiding sur-
gery, with all the risks and complications involved.
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Introduction
Ozurdex® (Allergan, USA) is a sustained-release dexa-
methasone implant used to treat various vitreoretinal
diseases [1]. A challenging complication of the intravitreal
injection of Ozurdex® is the migration to the anterior
chamber in decompartmentalized patients. Reported first
time by Pardo-López et al. in 2012 [2], Ozurdex®migration
to the anterior chamber requires an immediate resolution,
as it can cause permanent endothelial damage to the
cornea [3], [4]. Speed in treating this complication is the
key for a good prognosis, since taking a long time before
removing the implant from the anterior chamber is asso-
ciated with a worse endothelial account and lower visual
acuity [4].
Case description
We present the case of a 78-year-old woman with a
pseudoexfoliative syndrome. She had been operated for
cataracts in both eyes, without incident. Five years later,
her left eye developed IOL-capsular bag complex sublux-
ation, for which she was operated again, fixing the IOL-
capsular bag complex to the sclera with nylon suture
(SFIOL). Afterwards, she developed macular edema and
received an intravitreal injection of Ozurdex®.
Three weeks after the injection, she came to the emer-
gency room complaining of “blurred vision”. Visual acuity
was 10/200. The slit lamp examination confirmed the
presence of the implant in the inferior angle of the anteri-
or chamber, with corneal edema associated.
At that moment, postural relocation was the course of
action that was decided upon. The patient’s pupil was
dilated with tropicamide and phenylephrine to the max-
imum dosage. Even so, dilation was medium-low. The
patient was placed in a stretcher, lying in a supine posi-
tion with her head leaning out, and she was asked to look
up to her hair. That way, the dexamethasone implant
couldmove from the inferior to the superior angle. At first,
the implant did not move, as it was adhered to the
structures of the inferior angle. Topical anaesthesia was
instilled and a gentle massage of the globe was per-
formed. After thirty seconds, the implant moved from the
inferior to the superior angle, changing from horizontal
to vertical position. After that, the patient’s head was el-
evated to facilitate the inferior tip of the implant to pass
under the pupil and then the whole implant entered the
vitreous chamber by asking the patient to look down
(Figure 1, Figure 2).
Pilocarpine drops were prescribed and the patient was
instructed to avoid prone position. She was closely fol-
lowed for one year, with good IOP control. Corneal en-
dothelium cell count was of 2,167 cells in her right eye
and 547 cells in her left eye, which was the one that un-
derwent the aforementioned complication. The implant
did not migrate again and visual acuity remained stable
in 20/100.
Discussion
The treatment options for Ozurdex® migration to the an-
terior chamber are various: surgical extraction with for-
ceps, surgical extraction with aspirator, surgical extraction
with viscoelastic, surgical relocation to the vitreous
chamber with viscoelastic, and non-surgical postural re-
location [4], [5], [6], [7], [8]. For this last option, very little
has been published.
In articles concerning treatment for anterior chamber
migrated dexamethasone implants, posturalmanagement
is rarely mentioned. The technique is usually described
as “dilating the pupil and advising supine positioning”
and it has been proven to work in certain cases.
One of the most interesting points about this case is the
fact that the implant correctly relocated to the vitreous
chamber even though there was an SFIOL. To our know-
ledge, this is the second time [6] in the published literat-
ure that postural treatment is used to treat a patient with
SFIOL and a dexamethasone implant migrated to the
anterior chamber.
Surgical extraction of an Ozurdex® implant presents sev-
eral problems: Firstly, the patient was treated with a
dexamethasone implant because of vitreoretinal patho-
logy. By extracting it, we would extract a therapeutic
medication. Moreover, the extraction surgery, as with any
other surgery, is injurious to the corneal endothelium and
therefore can worsen endothelium cell count [3]. It is also
worth noting that during the surgery, the dexamethasone
implant can be disrupted due to the manipulation and
subsequent fragmentation into many pieces [3]. Also, an
operating theatre with amicroscope, proper surgical tools,
and a fully trained anterior segment surgeon is required.
Conclusion
Relocating the implant instead of extracting it can occa-
sionally be a good approach. It presents some advant-
ages: the difficulty of a complete extraction is avoided,
as is another intravitreal injection which reduces treat-
ment costs. If the relocation process is carried out with
postural manoeuvres instead of surgery, it is possible to
resolve the case in the emergency room and treatment
is not delayed hours or days until an operating room is
made available.
Audiovisual material
A 3D reconstruction of the technique is included, as well
as an actual video of the procedure (Attachment 1).
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Figure 1: A) Ozurdex® located in the inferior angle. B) The patient lies in supine, with the head leaning out. C) At first, the implant
does not move. D) With gentle massage, the implant moves to the superior angle, in vertical position. E) The patient’s head is
elevated so the inferior tip of the implant can pass under the pupil. F) When the patient looks down, the implant moves back
to the vitreous chamber.
Figure 2: The images show the actualmoment when the dexamethasone implantmoves from the anterior to the vitrous chamber
through the pupil. A) Looking up, the implant moves to the superior angle. B) Looking down, the implant migrates back.
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